skip to Global Navigation Bar skip to main content


homeHome > About Us > Press Release > News

News

News Content
Daewoong Pharmaceuticals presents result of phase 3 clinical trial on Supect at The Korean Society of Hematology
Date 2016-05-31 Hit 7596
list
News List
Prev Daewoong Pharmaceuticals receives Prime Minister Commendation as an ‘Outstanding Company in Fair Gender Employment’
Next Daewoong Pharmaceutical presents its research results on ‘treatments for fibrosis and autoimmune disease’ at ACR